Publications by authors named "Kiran Dave"
Article Synopsis
- The study highlights the ongoing challenges faced by ulcerative colitis (UC) patients in Japan despite existing treatments, focusing on their health-related quality of life (HRQoL) and productivity losses.
- About 83.6% of participants were on non-biologic treatments, with a significant portion reporting persistent symptoms and a notable percentage experiencing anxiety and depression, which negatively impacted their work productivity by an average of 29.3%.
- The results emphasize the need for new interventions to improve treatment outcomes as many patients still experience high disease burden and indirect costs.
Aims: Present cost-effectiveness analysis of nivolumab monotherapy vs. commonly prescribed third-line (3 L+) treatment in small cell lung cancer (SCLC).
Materials And Methods: A three health states partitioned survival model (progression-free, progressed disease, and death; US payer perspective) was developed.